Last Price$11.2(0.5%)
Market Cap$1,458.3M
Last Earnings date
Sep'24
Q3 2024
$0.00
97.9% miss
$52.9M
2.5% miss
Next quarter EPS Estimate
$0.06
50.0%YoY
ENFN Earnings and Expectations
Revenue
Crunching data... Almost there!
ENFN EPS (Earnings Per Share)
Crunching data... Almost there!
ENFN Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
ENFN Earnings History
| Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $18.6M | $18.6M | $19.8M | $22.7M | $24.4M | $26.4M | $29.0M | $31.9M | $34.1M | $36.5M | $39.2M | $40.5M | $41.0M | $42.7M | $44.4M | $46.5M | $48.1M | $49.5M | $51.2M | $52.9M |
| Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $30.4M | $33.0M | $35.6M | $38.6M | $40.0M | $41.8M | $44.6M | $43.9M | $45.2M | $47.6M | $50.0M | $52.2M | $54.3M |
| Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.7% | 3.3% | 2.7% | 1.3% | 1.3% | 1.9% | 4.2% | 1.0% | 2.9% | 0.9% | 1.0% | 1.9% | 2.5% |
| EPS actual | $0.06 | $0.08 | $0.09 | ($0.19) | $0.06 | $0.07 | $0.05 | ($3.53) | ($0.16) | ($0.03) | $0.02 | $0.01 | $0.05 | $0.01 | $0.02 | $0.01 | ($0.01) | $0.02 | $0.02 | $0.00 |
| EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0.04 | $0.04 | $0.02 | $0.02 | $0.03 | $0.03 | $0.04 | $0.04 | $0.06 | $0.04 | $0.06 | $0.06 | $0.06 |
| EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10,047.0% | 484.0% | 243.0% | 10.5% | 70.0% | 89.7% | 83.4% | 50.7% | 87.3% | 116.5% | 64.9% | 63.0% | 97.9% |
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
$52.9M 13.9% YoY
Cost of revenue
$16.4M 5.0% YoY
Pre-tax income
$2,458.0K 12.8% YoY
4.6% margin
Competing with ENFN Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$1,458.3M | $201.6M | $0.04 | 13.9% | (81.7%) | Miss by 2.5% | Miss by 97.9% | 6.1% | 4,877.4% | Beats: 2 Misses: 8 | 16.2% | 110.8% | |
$322.5B | €34.2B | €4.05 | 10.7% | 169.6% | Miss by 1.7% | Beat by 103.3% | (0.1%) | (49.4%) | Beats: 3 Misses: 7 | 14.3% | 40.7% | |
$271.3B | $37.9B | $6.44 | 7.6% | 19.5% | undefinedN/A | undefinedN/A | (0.7%) | 47.2% | Beats: 8 Misses: 2 | 8.9% | 136.2% | |
$175.2B | $11.0B | $6.92 | 21.3% | 29.2% | Miss by 0.3% | Miss by 49.1% | 5.4% | 110.4% | Beats: 9 Misses: 1 | 20.5% | 139.8% | |
$170.7B | $17.2B | $10.84 | 17.0% | 33.3% | Beat by 26.2% | Miss by 28.8% | 89.7% | 585.4% | Beats: 9 Misses: 1 | 12.3% | 82.3% | |
$160.6B | $44.0B | $4.69 | 20.4% | 373.9% | Beat by 1.6% | Beat by 561.8% | (1.6%) | (86.0%) | Beats: Misses: | 14.9% | (49.5%) | |
$129.1B | $8,879.6M | $1.56 | 31.2% | 88.7% | Beat by 5.0% | Beat by 136.1% | (18.5%) | (72.5%) | Beats: 9 Misses: 1 | 20.7% | (2.9%) | |
$91.7B | $4,709.2M | $4.68 | 44.0% | 247.1% | Beat by 8.9% | Beat by 42.2% | (4.4%) | (27.3%) | Beats: 7 Misses: 3 | 20.0% | 29.0% | |
$66.2B | $4,641.3M | $3.89 | 26.9% | 4.2% | Beat by 0.7% | Miss by 31.3% | (7.5%) | 26.0% | Beats: 9 Misses: 1 | 13.0% | 75.7% | |
$63.6B | $463.5M | ($5.63) | (3.0%) | N/A | Miss by 1.9% | Beat by 2,467.8% | (4.0%) | (96.5%) | Beats: 3 Misses: 7 | 3.2% | (87.0%) |
FAQ
1. When was Enfusion, Inc.'s last earnings date?
Enfusion, Inc.'s last earnings date was Sep'24 (Q3 2024).
2. What is Enfusion, Inc.'s EPS, and was there a surprise?
Enfusion, Inc.'s EPS was $0.00, with a 97.9% miss.
3. What is Enfusion, Inc.'s revenue, and was there a surprise?
Enfusion, Inc.'s revenue was $52.9M, with a 2.5% miss.
4. What is Enfusion, Inc.'s next quarter EPS estimate?
Enfusion, Inc.'s next quarter EPS estimate is $0.06, with an expected 50.0% YoY growth.